EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development

Mohamed Mustaf Ahmed iD, Olalekan John Okesanya iD, Bonaventure Michael Ukoaka iD, Adamu Muhammad Ibrahim, Don Eliseo Lucero-Prisno

Viruses · 2024

DOI: 10.3390/v16121933 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Mohamed Mustaf Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu 252, Somalia. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Immune Evasion, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vesicular stomatitis virus (VSV) represents a significant advancement in therapeutic medicine, offering unique molecular and cellular characteristics that make it exceptionally suitable for medical applications. The bullet-shaped morphology, RNA genome organization, and cytoplasmic replication strategy provide fundamental advantages for both vaccine development and oncolytic applications. VSV’s interaction with host cells through the low-density lipoprotein receptor (LDL-R) and its sophisticated transcriptional regulation mechanisms enables precise control over therapeutic applications. The virus demonstrates remarkable versatility through its rapid replication cycle, robust immune response induction, and natural neurotropism. Recent technological innovations in VSV engineering have led to enhanced safety protocols and improved therapeutic modifications, particularly in cancer treatment. Attenuation strategies have successfully addressed safety concerns while maintaining the therapeutic efficacy of the virus. The molecular and cellular interactions of VSV, particularly its immune modulation capabilities and tumor-selective properties, have proven valuable in the development of targeted therapeutic strategies. This review explores these aspects, while highlighting the continuing evolution of VSV-based therapeutic approaches in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirusesOncolytic VirotherapyImmune EvasionNeoplasmsHumansAnimalsVaccine DevelopmentVesiculovirusVirus Replication

Stichwörter der Autor:innen

immune evasiononcolytic virotherapypathogenesisvaccine vectorvesicular stomatitis virus

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu 252, Somalia.
  • Department of Medical Laboratory Science, Neuropsychiatric Hospital, Aro, Abeokuta 110101, Nigeria.
  • Community and Clinical Research Division, First On-Call Initiative, Port Harcourt 500001, Nigeria.
  • Department of Immunology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto 840001, Nigeria.
  • Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Research and Innovation Office, Southern Leyte State University, Leyte 6500, Philippines.

ORCID-Profile: Mohamed Mustaf Ahmed, Olalekan John Okesanya, Bonaventure Michael Ukoaka

Zitieren

APA

Ahmed, M. M., Okesanya, O. J., Ukoaka, B. M., Ibrahim, A. M., & Lucero-Prisno, D. E. (2024). Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development. Viruses. https://doi.org/10.3390/v16121933

Vancouver

Ahmed MM, Okesanya OJ, Ukoaka BM, Ibrahim AM, Lucero-Prisno DE. Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development. Viruses. 2024. doi:10.3390/v16121933

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Mohamed Mustaf and Okesanya, Olalekan John and Ukoaka, Bonaventure Michael and Ibrahim, Adamu Muhammad and Lucero-Prisno, Don Eliseo},
  title = {Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16121933}
}
Kostenlos starten →